RCT: Topical imiquimod versus surgery for vulvar intraepithelial neoplasia.
3 May, 2022 | 10:30h | UTCTopical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial – The Lancet (link to abstract – $ for full-text)